Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

STOP-COVID (Guimarães)
 
NCT04469114
RCTtofacitinibplaceboCOVID 19 hospitalizedlow
144/145 conclusif
  • demonstrated 37 % decrease in death or ventilation (PE) with a high degree of certainty due to low risk of bias
1 study excluded by filtering options (1 RCT / 0 OBS)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).